Arginine deiminase, a potential anti-tumor drug

Cancer Letters

Volumn 261, Issue 1, 2008, Pages 1-11

  Ni, Ye ^a   Schwaneberg, Ulrich ^b   Sun, Zhi Hao ^a  

^a JIANGNAN UNIVERSITY   (China)

^b JACOBS UNIVERSITY BREMEN   (Germany)

Author keywords

Anti tumor; Arginine; Arginine deiminase; Cancer; Drug

Indexed keywords

ADI PEG 20; ANTINEOPLASTIC AGENT; ARGININE DEIMINASE; ASPARAGINASE; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ANAPHYLACTIC SHOCK; ANTINEOPLASTIC ACTIVITY; BLOOD CLOTTING DISORDER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG ISOLATION; ENZYME ACTIVITY; HUMAN; IMMUNOGENICITY; LEUKEMIA; LIVER CELL CARCINOMA; LIVER TOXICITY; LYMPHATIC LEUKEMIA; MELANOMA; MICROORGANISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIDE EFFECT; STRUCTURE ANALYSIS;

EID: 39149099417     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.038     Document Type: Review

References (56)

1. Ensor C.M., Holtsberg F.W., Bomalaski J.S., and Clark M.A. Pegylated arginine deiminase (ADI-ssPEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res. 62 (2002) 5443-5450
2. Shen L.J., and Shen W.C. Drug evaluation: ADI-PEG-20 - a PEGylated arginine deiminase for arginine-auxotrophic cancers. Curr. Opin. Mol. Ther. 8 (2006) 240-248
3. Gong H., Zölzer F., von Recklinghausen G., Havers W., and Schweigerer L. Arginine deiminase inhibits proliferation of human leukaemia cells more potently than asparginase by inducing cell cycle arrest and apoptosis. Leukemia 14 (2000) 826-829
4. Beloussow K., Wang L., Wu J., Ann D., and Shen W.C. Recombinant arginine deiminase as a potential anti-angiogenic agent. Cancer Lett. 183 (2002) 55-162
5. Park I.S., Kang S.W., Shin Y.J., Chae K.Y., Park M.O., Kim M.Y., Wheatley D.N., and Min B.H. Arginine deminase: a potential inhibitor of angiogenesis and tumor growth. Br. J. Cancer 89 (2003) 907-914
6. Izzo F., Marra P., Beneduce G., Castello G., Vallone P., De Rosa V., Cremona F., Ensor C.M., Holtsberg F.W., Bomalaski J.S., Clark M.A., Ng C., and A Curley S. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from Phase I/II studies. J. Clin. Oncol. 22 (2004) 1815-1822
7. Holtsberga F.W., Ensora C.M., Steinerc M.R., Bomalaskia J.S., and Clark M.A. Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties. J. Control. Release 80 (2002) 259-271
8. Wheatley D.N., and Campbell E. Arginine catabolism, liver extracts and cancer. Pathol. Oncol. Res. 8 (2002) 18-25
9. Wheatley D.N. Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells. Semin. Cancer Biol. 15 (2005) 247-253
10. Zuniga M., Perez G., and Gonzalez-Candelas F. Evolution of arginine deiminase (ADI) pathway genes. Mol. Phylogenet. Evol. 25 (2002) 429-444
11. Horn F. The breakdown of arginine to citrulline by Bacillus pyocyaneus. Hoppe-Seyler's Z. Physiol. Chem. 216 (1933) 244-247
12. Kakimoto T., Shibatani T., and Chibata I. Crystallization of l-arginine deiminase from Pseudomonas putida. FEBS Lett. 19 (1971) 166-168
13. Shibatani T., Kakimoto T., and Chibata I. Crystallization and properties of l-arginine deiminase of Pseudomonas putida. J. Biol. Chem. 250 (1975) 4580-4583
14. Galkin A., Kulakova L., Sarikaya E., Lim K., Howard A., and Herzberg O. Structural insight into arginine degradation by arginine deiminase, an antibacterial and parasite drug target. J. Biol. Chem. 279 (2004) 14001-14008
15. Lu X., Li L., Wu R., Feng X., Li Z., Yang H., Wang C., Guo H., Galkin A., Herzberg O., Mariano P.S., Martin B.M., and Dunaway-Mariano D. Kinetic analysis of Pseudomonas aeruginosa arginine deiminase mutants and alternate substrates provides insight into structural determinants of function. Biochemistry 45 (2006) 1162-1172
16. Z.H. Sun, P. Zheng, Y. Ni, Y.M. Liu, Y.P. Liu, An arginine deiminase producing strain and its application, Chinese patent (Application No. 200710107822.X).
17. Weickmann J.L., and Fahrney D.E. Arginine deiminase from Mycoplasma arthritidis. Evidence for multiple forms. J. Biol. Chem. 252 (1977) 2615-2620
18. Ohno T., Ando O., Sugimura K., Taniai M., Suzuki M., Fukuda S., Nagase Y., Yamamoto K., and Azuma I. Cloning and nucleotide sequence of the gene encoding arginine deiminase of Mycoplasma arginini. Infect. Immun. 58 (1990) 3788-3795
19. Takaku H., Takase M., Abe S.-I., Hayashi H., and Miyazaki K. In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int. J. Cancer 51 (1992) 244-249
20. Takaku H., Matsumoto M., Misawa S., and Miyazaki M. Anti-tumor activity of arginine deiminase from Mycoplasma arginini and its growth-inhibitory mechanism. Jpn. J. Cancer Res. 86 (1995) 840-846
21. Monstadt G.M., and Holldorf A.W. Arginine deiminase from Halobacterium salinarium Purification and properties. Biochem. J. 273 (1990) 739-745
22. De Angelis M., Mariotti L., Rossi J., Servili M., Fox P.F., Rollán G., and Gobbetti M. Arginine catabolism by sourdough lactic acid bacteria: purification and characterization of the arginine deiminase pathway enzymes from Lactobacillus sanfranciscensis CB1. Appl. Environ. Microbiol. 68 (2002) 6193-6201
23. Kim J.E., Jeong D.W., and Lee H.J. Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21. Protein Expr. Purif. 53 (2007) 9-15
24. Knodler L.A., Schofield P.J., Gooley A.A., and Edwards M.R. Giardia intestinalis: purification and partial amino acid sequence of arginine deiminase. Exp. Parasitol. 85 (1997) 77-80
25. Linstead D., and Cranshaw M.A. The pathway of arginine catabolism in the parasitic flagellate Trichomonas vaginalis. Mol. Biochem. Parasitol. 8 (1983) 241-252
26. Yarlett N., Lindmark D.G., Goldberg B., Moharrami M.A., and Bacchi C.J. Subcellular localization of the enzymes of the arginine dihydrolase pathway in Trichomonas vaginalis and Tritrichomonas foetus. J. Eukaryot. Microbiol. 41 (1994) 554-559
27. J.B. Jones, The effect of arginine deiminase on murine leukemia lymphoblasts (Ph.D. dissertation), Oklahoma City, OK, University of Oklahoma, 1981.
28. Miyazaki K., Takaku H., Umeda M., Fujita T., Huang W.D., Kimura T., Yamashita J., and Horio T. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a mycoplasma-infected cell line. Cancer Res. 50 (1990) 4522-4527
29. Takaku H., Misawa S., Hayashi H., and Miyazaki K. Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini. Jpn. J. Cancer Res. 84 (1993) 1195-1200
30. Gong H., Zolze F., von Recklinghausen G., Rössler J., Breit S., Havers W., Fotsis T., and Schweigerer L. Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis. Biochem. Biophys. Res. Commun. 261 (1999) 10-14
31. Durden D.L., and Distasio J.A. Comparison of the immunosuppressive effects of asparaginases from Escherichia coli and Vibrio succinogenes. Cancer Res. 40 (1980) 1125-1129
32. Mûller H.J., and Boos J. Use of l-asparaginase in childhood ALL. Crit. Rev. Oncol. Hematol. 28 (1998) 97-113
33. Shen L.J., Beloussow K., and Shen W.C. Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase. Cancer Lett. 231 (2006) 30-35
34. Burne R.A., Parsons D.T., and Marquis R.E. Cloning and expression in Escherichia coli of the genes of the arginine deiminase system of Streptococcus sanguis NCTC 10904. Infect. Immun. 57 (1989) 3540-3548
35. Kondo K., Sone H., Yoshida H., Toida T., Kanatani K., Hong Y.M., Nishino N., and Tanaka J. Cloning and sequence analysis of the arginine deiminase gene from Mycoplasma arginini. Mol. Gen. Genet. 221 (1990) 81-86
36. Misawa S., Aoshima M., Takaku H., Matsumoto M., and Hayashi H. High-level expression of Mycoplasma arginini deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J. Biotechnol. 36 (1994) 145-155
37. Knodler L.A., Sekyere E.O., Stewart T.S., Schofield P.J., and Edwards M.R. Cloning and expression of a prokaryotic enzyme, arginine deiminase, from a primitive eukaryote Giardia intestinalis. J. Biol. Chem. 273 (1998) 4470-4477
38. Oudjama Y., Tricot C., Stalon V., and Wouters J. Overexpression, purification, crystallization and preliminary X-ray crystallographic analysis of Pseudomonas aeruginosa l-arginine deiminase. Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 2150-2152
39. Galkin A., Lu X., Dunaway-Mariano D., and Herzberg O. Crystal structures representing the Michaelis complex and the thiouronium reaction intermediate of Pseudomonas aeruginosa arginine deiminase. J. Biol. Chem. 280 (2005) 34080-34087
40. Das K., Butler G.H., Kwiatkowski V., Clark Jr. A.D., Yadav P., and Arnold E. Crystal structures of arginine deiminase with covalent reaction intermediates: implications for catalytic mechanism. Structure 12 (2004) 657-667
41. Humphrey W., Dalke A., and Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 14 (1996) 33-38
42. Wang C., Xu D., Zhang L., Xie D., and Guo H. Molecular dynamics and density functional studies of substrate binding and catalysis of arginine deiminase. J. Phys. Chem. B 111 (2007) 3267-3273
43. Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 72 (2006) 211-222
44. Westers L., Westers H., and Quax W.J. Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim. Biophys. Acta 1694 (2004) 299-310
45. Bloom J.D., Meyer M.M., Meinhold P., Otey C.R., MacMillan D., and Arnold F.H. Evolving strategies for enzyme engineering. Curr. Opin. Struct. Biol. 15 (2005) 447-452
46. Chen K., and Arnold F.H. Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide. Proc. Natl. Acad. Sci. USA 90 (1993) 5618-5622
47. Stemmer W.P.C. Rapid evolution of a protein in vitro by DNA shuffling. Nature 370 (1994) 389-391
48. Zhang J.-H., Dawes G., and Stemmer W.P.C. Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening. Proc. Natl. Acad. Sci. USA 94 (1997) 4504-4509
49. Kumamaru T., Suenaga H., Mitsuoka M., Watanabe T., and Furukawa K. Enhanced degradation of polychlorinated biphenyls by directed evolution of biphenyl dioxygenase. Nat. Biotechnol. 16 (1998) 663-666
50. Cherry J.R., Lamsa M.H., Schneider P., Vind J., Svendsen A., Jones A., and Pedersen A.H. Directed evolution of a fungal peroxidase. Nat. Biotechnol. 17 (1999) 379-384
51. Liu Z., Sun Z., and Leng Y. Directed evolution and characterization of a novel d-pantonohydrolase from Fusarium moniliforme. J. Agric. Food Chem. 54 (2006) 5823-5830
52. Abuchowski A., van Es T., Palczuk N.C., and Davis F.F. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252 (1977) 3578-3581
53. Abuchowski A., McCoy J.R., Palczuk N.C., van Es T., and Davis F.F. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 252 (1977) 3582-3586
54. Veronese F.M., and Pasut G. PEGylation, successful approach to drug delivery. Drug Discov. Today 10 (2005) 1451-1458
55. R. Fleer, A. Fournier, J.-D. Guitton, G. Jung; P. Yeh, Fusion polypeptides comprising human serum albumin, nucleic acids encoding same, and recombinant expression thereof, US Patent No. 5,876,969. Issue Date, March 2, 1999.
56. Chuang V.T., Kragh-Hansen U., and Otagiri M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm. Res. 19 (2002) 569-577